Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM).

Humans Italy Medical Oncology Neoplasms, Glandular and Epithelial / diagnosis Thymus Neoplasms / diagnosis
AIOM recommendations thymic epithelial tumors

Journal

ESMO open
ISSN: 2059-7029
Titre abrégé: ESMO Open
Pays: England
ID NLM: 101690685

Informations de publication

Date de publication:
08 2021
Historique:
received: 29 01 2021
revised: 12 04 2021
accepted: 24 05 2021
pubmed: 12 6 2021
medline: 30 10 2021
entrez: 11 6 2021
Statut: ppublish

Résumé

The Italian Association of Medical Oncology recommendations on thymic epithelial tumors, which have been drawn up for the first time in 2020 through an evidence-based approach, report indications on all the main aspects of clinical management of this group of rare diseases, from diagnosis and staging, to new available systemic treatments, such as targeted therapies and immunotherapies. A summary of key recommendations is presented here and complete recommendations are reported as Supplementary Materials, available at https://doi.org/10.1016/j.esmoop.2021.100188.

Identifiants

DOI: 10.1016/j.esmoop.2021.100188 PMID: 34116501 PMC: PMC8193108
pubmed: 34116501
pii: S2059-7029(21)00149-6
doi: 10.1016/j.esmoop.2021.100188
pmc: PMC8193108
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100188

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors have declared no conflicts of interest.

Auteurs

F Conforti (F)

Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, Istituto Europeo di Oncologia, IRCCS, Milan, Italy. Electronic address: fabio.conforti@ieo.it.

M Marino (M)

Department of Pathological Anatomy, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.

V Vitolo (V)

National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.

L Spaggiari (L)

Department of Thoracic Surgery, IRCCS European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.

R Mantegazza (R)

Department of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

P Zucali (P)

Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano, Italy.

E Ruffini (E)

Department of Thoracic Surgery, San Giovanni Battista Hospital, University of Torino, Torino, Italy.

L di Tommaso (L)

Department of Pathology, Humanitas Clinical and Research Center, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.

G Pelosi (G)

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

M Barberis (M)

Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

I Petrini (I)

Department of Critical Area and Surgical, Medical and Molecular Pathology, University of Pisa, Pisa, Italy.

G Palmieri (G)

Scientific Direction, Department of Clinical Medicine and Surgery, Rare Tumors Reference Center, University Federico II, Naples, Italy.

G Pasello (G)

Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

G Galli (G)

Thoracic Oncology, Medical Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

R Berardi (R)

Medical Oncology Unit, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Ancona, Italy.

M Garassino (M)

Thoracic Oncology, Medical Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

P Filosso (P)

Thoracic Surgery Unit, University of Torino, Torino, Italy.

M Alloisio (M)

Department of Neurosurgery, Humanitas Clinical and Research Center-IRCSS, Rozzano, Italy.

M Scorsetti (M)

Department of Radiotherapy and Radiosurgery, Humanitas Clinical and Research Center-IRCSS, Rozzano, Italy.

R Orecchia (R)

Scientific Direction, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

L Pala (L)

Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.

L Abatedaga (L)

Associazione TU.TO.R. Tumori Toracici Rari, Milan, Italy.

S Cinieri (S)

Medical Oncology Unit, Antonio Perrino Hospital, Brindisi, Italy.

T De Pas (T)

Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Clinical management of patients with thymic...
questionsmedicales.fr › Régions géographiques › Europe › Italie › Clinical management of patients with thymic...
questionsmedicales.fr › Professions de santé › Médecine › Médecine interne › Oncologie médicale › Clinical management of patients with thymic...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Clinical management of patients with thymic...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Maladies lymphatiques › Tumeurs du thymus › Clinical management of patients with thymic...